Corcept Therapeutics
CORT
#2446
Rank
$5.84 B
Marketcap
$55.40
Share price
2.03%
Change (1 day)
133.26%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of December 2024 : $0.38 Billion USD

According to Corcept Therapeutics 's latest financial reports the company has $0.38 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.38 B4.1%
2023-12-31$0.36 B-14.7%
2022-12-31$0.43 B93.11%
2021-12-31$0.22 B-49.28%
2020-12-31$0.44 B59.69%
2019-12-31$0.27 B33.47%
2018-12-31$0.20 B132.98%
2017-12-31$88.74 M72.2%
2016-12-31$51.53 M27.45%
2015-12-31$40.43 M66.76%
2014-12-31$24.24 M-55.81%
2013-12-31$54.87 M-41.01%
2012-12-31$93.03 M134.72%
2011-12-31$39.63 M61.26%
2010-12-31$24.57 M2.98%
2009-12-31$23.86 M30.36%
2008-12-31$18.3 M5.43%
2007-12-31$17.36 M83.65%
2006-12-31$9.45 M-67.48%
2005-12-31$29.08 M-22.25%
2004-12-31$37.4 M223.06%
2003-12-31$11.57 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$24.52 B 6,297.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.85 B 2,732.78%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.35 B 3,382.86%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$3.42 B 793.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.47 B 5,241.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.68 B 3,471.04%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.14 B-62.25%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.19 B-48.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.13 B 196.79%๐Ÿ‡บ๐Ÿ‡ธ USA